JFA
IMI

JNBA Financial Advisors’s Intermolecular, Inc. IMI Stock Holding History

JNBA Financial Advisors’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,500
Closed -$19K – 771
2018
Q3 		$19K Buy
+16,500
New +$23.6K 0.01% 323

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JNBA Financial Advisors's IMI Position: Q4 2018 in Review

JNBA Financial Advisors sold out of Intermolecular, Inc. (IMI) in Q4 2018, closing a stake of 16,500 shares — an estimated $19K sold.

JNBA Financial Advisors first reported a position in IMI in Q3 2018 and held it in 1 quarter. The position peaked at $19K in Q3 2018. 32 funds tracked by Wall St. Rank hold IMI as of Q4 2018.

  • JNBA Financial Advisors reported no remaining Intermolecular, Inc. position as of Q4 2018 after selling out during the quarter.
  • JNBA Financial Advisors sold 16,500 Intermolecular, Inc. shares in Q4 2018, an estimated $19K.
  • JNBA Financial Advisors first reported a position in Intermolecular, Inc. in Q3 2018 and held it in 1 quarter.
  • JNBA Financial Advisors's Intermolecular, Inc. position peaked at $19K in Q3 2018.
  • 32 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q4 2018.

Based on JNBA Financial Advisors's 13F filing for Q4 2018, filed 7 Feb 2019.